1. Bone morphogenetic protein induces bone invasion of melanoma by epithelial–mesenchymal transition via the Smad1/5 signaling pathway
- Author
-
Ryusuke Muroya, Mayuko Inoue, Jing Gao, Yudai Tajiri, Koji Okabe, Masashi Shin, Fei Huang, Ryoko Nagano, Kazuhiro Aoki, Takayoshi Yamaza, Yukihiko Tamura, Shinsuke Fujii, Tamotsu Kiyoshima, Miho Matsuda, Toshio Kukita, Kengo Nagata, Eijiro Jimi, Yoshihide Mori, and Sakura Chishaki
- Subjects
Male ,Epithelial-Mesenchymal Transition ,animal structures ,Bone Neoplasms ,Bone morphogenetic protein ,Bone morphogenetic protein 2 ,Bone and Bones ,Pathology and Forensic Medicine ,Mice ,Downregulation and upregulation ,Osteoclast ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Neoplasm Invasiveness ,Epithelial–mesenchymal transition ,Melanoma ,neoplasms ,Molecular Biology ,Chemistry ,Cell Biology ,medicine.disease ,Smad Proteins, Receptor-Regulated ,Bone morphogenetic protein 7 ,medicine.anatomical_structure ,Bone Morphogenetic Proteins ,embryonic structures ,Cancer research ,Mouth Neoplasms ,Signal transduction ,Signal Transduction - Abstract
Oral malignant melanoma, which frequently invades the hard palate or maxillary bone, is extremely rare and has a poor prognosis. Bone morphogenetic protein (BMP) is abundantly expressed in bone matrix and is highly expressed in malignant melanoma, inducing an aggressive phenotype. We examined the role of BMP signaling in the acquisition of an aggressive phenotype in melanoma cells in vitro and in vivo. In five cases, immunohistochemistry indicated the phosphorylation of Smad1/5 (p-Smad1/5) in the nuclei of melanoma cells. In the B16 mouse and A2058 human melanoma cell lines, BMP2, BMP4, or BMP7 induces morphological changes accompanied by the downregulation of E-cadherin, and the upregulation of N-cadherin and Snail, markers of epithelial-mesenchymal transition (EMT). BMP2 also stimulates cell invasion by increasing matrix metalloproteinase activity in B16 cells. These effects were canceled by the addition of LDN193189, a specific inhibitor of Smad1/5 signaling. In vivo, the injection of B16 cells expressing constitutively activated ALK3 enhanced zygoma destruction in comparison to empty B16 cells by increasing osteoclast numbers. These results suggest that the activation of BMP signaling induces EMT, thus driving the acquisition of an aggressive phenotype in malignant melanoma.
- Published
- 2021
- Full Text
- View/download PDF